Liver SpotsSymptoms, Doctors, Treatments, Advances & More
Learn About Liver Spots
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Avera Medical Group Dermatology — Mitchell
Mandi Greenway, MD, a dermatologist, provides expert skin care for people of all ages at Avera Medical Group Dermatology in Mitchell, SD. Dr. Greenway is rated as an Advanced provider by MediFind in the treatment of Liver Spots. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Warts, Seborrheic Keratosis, and Melanoma. Dr. Greenway is board certified in American Board Of Dermatology.
Holladay Clinic - Dermatology
Jana Parker is a Dermatologist practicing medicine in Murray, Utah. She has been practicing medicine for over 23 years. Dr. Parker is rated as an Advanced provider by MediFind in the treatment of Liver Spots. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Sunburn, Actinic Keratosis, Melanoma, and Liver Spots. Dr. Parker is board certified in American Board Of Dermatology.
Avera Dermatology — Pierre
Dr. (Joyce) Wesley Fletcher is a dermatologist at Avera Medical Group in Pierre, located in the Helmsley Center at Avera St. Mary's Hospital. Dr. Fletcher is rated as an Advanced provider by MediFind in the treatment of Liver Spots. She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, and Neurocutaneous Melanosis.
Summary: The objective of this study is to evaluate the efficacy, cosmetic acceptability and improvement of the stigmatization of the tested product (2039125 03) used bis in die (BID) for 3 months in adult patients suffering from mild to moderate melasma, or mild to moderate acne induced post-inflammatory hyperpigmentation, or solar lentigo.
Summary: The objective of this study is to evaluate the efficacy, cosmetic acceptability and improvement of the stigmatization of the tested product (2039125 03) used bis in die (BID) for 3 months in adult patients suffering from mild to moderate melasma, or mild to moderate acne induced post-inflammatory hyperpigmentation, or solar lentigo.